tirzepatide semaglutide head to head Cardiovascular outcomes of and for patients with type 2 diabetes in clinical practice Tirzepatide vs semaglutide: A new

The findings of a new study suggest that an apparent association between GLP-1 medications and thyroid cancer may be due to more intensive patient screening, and not a side effect of the drugs themselves.

Tirzepatide was approved in 2022 as Mounjaro for diabetes, and in 2024 as Zepbound for obesity, with exclusivity running until May 2027

Learn about GLP-1 drug interactions & nutrient deficiencies with Ozempic, Wegovy & Mounjaro

Generic drugs have saved consumers billions of dollars in the United States

Offering sublingual tirzepatide options for effective treatment to support your weight loss journey.

Part of the Elite Research Labs Veltrix Series, this compound is manufactured and verified for consistency, purity, and research reliability across controlled experimental environments